BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17289835)

  • 1. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18.
    Wannamaker W; Davies R; Namchuk M; Pollard J; Ford P; Ku G; Decker C; Charifson P; Weber P; Germann UA; Kuida K; Randle JC
    J Pharmacol Exp Ther; 2007 May; 321(2):509-16. PubMed ID: 17289835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients.
    Stack JH; Beaumont K; Larsen PD; Straley KS; Henkel GW; Randle JC; Hoffman HM
    J Immunol; 2005 Aug; 175(4):2630-4. PubMed ID: 16081838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production.
    Ravizza T; Noé F; Zardoni D; Vaghi V; Sifringer M; Vezzani A
    Neurobiol Dis; 2008 Sep; 31(3):327-33. PubMed ID: 18632279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme.
    Zhang Y; Hegen M; Xu J; Keith JC; Jin G; Du X; Cummons T; Sheppard BJ; Sun L; Zhu Y; Rao VR; Wang Q; Xu W; Cowling R; Nickerson-Nutter CL; Gibbons J; Skotnicki J; Lin LL; Levin J
    Int Immunopharmacol; 2004 Dec; 4(14):1845-57. PubMed ID: 15531300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
    Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
    Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice.
    Maroso M; Balosso S; Ravizza T; Iori V; Wright CI; French J; Vezzani A
    Neurotherapeutics; 2011 Apr; 8(2):304-15. PubMed ID: 21431948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and mechanisms of potent caspase-1 inhibitor VX765 treatment on collagen-induced arthritis in mice.
    Zhang Y; Zheng Y
    Clin Exp Rheumatol; 2016; 34(1):111-8. PubMed ID: 26742834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-1 involves in bilirubin-induced injury of cultured rat cortical neurons.
    He C; Feng J; Huang H; Hua Z
    Pediatr Res; 2019 Oct; 86(4):492-499. PubMed ID: 31195405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VX-765 ameliorates inflammation and extracellular matrix accumulation by inhibiting the NOX1/ROS/NF-κB pathway in diabetic nephropathy.
    Wang X; Wu T; Ma H; Huang X; Huang K; Ye C; Zhu S
    J Pharm Pharmacol; 2022 Mar; 74(3):377-386. PubMed ID: 34383065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.
    Weber P; Wang P; Maddens S; Wang PSh; Wu R; Miksa M; Dong W; Mortimore M; Golec JM; Charlton P
    Crit Care; 2009; 13(5):R146. PubMed ID: 19740426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.
    Li S; Fossati G; Marchetti C; Modena D; Pozzi P; Reznikov LL; Moras ML; Azam T; Abbate A; Mascagni P; Dinarello CA
    J Biol Chem; 2015 Jan; 290(4):2368-78. PubMed ID: 25451941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
    Wen S; Deng F; Li L; Xu L; Li X; Fan Q
    J Diabetes Investig; 2022 Jan; 13(1):22-33. PubMed ID: 34494385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs.
    Randle JC; Harding MW; Ku G; Schönharting M; Kurrle R
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1207-9. PubMed ID: 11772244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and anti-arthritic effects of the ethanolic extract of Aralia continentalis Kitag. in IL-1β-stimulated human fibroblast-like synoviocytes and rodent models of polyarthritis and nociception.
    Hong R; Sur B; Yeom M; Lee B; Kim KS; Rodriguez JP; Lee S; Kang KS; Huh CK; Lee SC; Hahm DH
    Phytomedicine; 2018 Jan; 38():45-56. PubMed ID: 29425654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel Pd-catalyzed N-acyl vinylogous carbamate synthesis for the key intermediate of ICE inhibitor VX-765.
    Tanoury GJ; Chen M; Dong Y; Forslund RE; Magdziak D
    Org Lett; 2008 Jan; 10(2):185-8. PubMed ID: 18081302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
    Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR
    Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway.
    Sun Z; Gu L; Wu K; Wang K; Ru J; Yang S; Wang Z; Zhuge Q; Huang L; Huang S
    CNS Neurosci Ther; 2020 Sep; 26(9):952-961. PubMed ID: 32459063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-κB activation.
    Li Q; Dai Z; Cao Y; Wang L
    Biochem Biophys Res Commun; 2019 May; 513(2):479-485. PubMed ID: 30979498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.